Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care.

Our main focus are the neurodegenerative diseases (CSF and plasma markers), infectious diseases and oncology.